These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24772510)

  • 1. [Use of fendivia transdermal therapeutic system in Russian patients with malignant neoplasms during palliative care: pharmacoeconomic aspects].
    Ryazhenov VV; Abuzarova GR; Gorokhova SG; Emchenko IV; Matveev NV
    Ter Arkh; 2014; 86(2):63-8. PubMed ID: 24772510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the resources used in advanced cancer care between two different strong opioids: an analysis of naturalistic practice in the UK.
    Guest JF; Ruiz FJ; Russ J; Gupta RD; Mihai A; Greener M
    Curr Med Res Opin; 2005 Feb; 21(2):271-80. PubMed ID: 15801998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calculating the cost for drug treatment including the adverse drug reactions treatment cost (primer for fentanyl TTS in Bulgaria).
    Petrova GI; Getov IN
    Boll Chim Farm; 2002; 141(2):150-3. PubMed ID: 12135164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pain management of cancer patients with transdermal fentanyl: a study of 1828 step I, II, & III transfers.
    Mystakidou K; Parpa E; Tsilika E; Katsouda E; Kouloulias V; Kouvaris J; Georgaki S; Vlahos L
    J Pain; 2004 Mar; 5(2):119-32. PubMed ID: 15042520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany.
    Greiner W; Lehmann K; Earnshaw S; Bug C; Sabatowski R
    Eur J Health Econ; 2006 Dec; 7(4):290-6. PubMed ID: 16983521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
    van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
    Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low doses of transdermal fentanyl in opioid-naive patients with cancer pain.
    Mercadante S; Porzio G; Ferrera P; Aielli F; Adile C; Ficorella C
    Curr Med Res Opin; 2010 Dec; 26(12):2765-8. PubMed ID: 21034376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
    Otis J; Rothman M
    Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A one year health economic model comparing transdermal fentanyl with sustained-release morphine in the treatment of chronic noncancer pain.
    Frei A; Andersen S; Hole P; Jensen NH
    J Pain Palliat Care Pharmacother; 2003; 17(2):5-26. PubMed ID: 14649386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Transdermal fentanyl].
    Lossignol D; Sternon J
    Rev Med Brux; 1998 Apr; 19(2):83-6. PubMed ID: 9643088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal fentanyl for severe cancer-related pain.
    Yeo W; Lam KK; Chan AT; Leung TW; Nip SY; Johnson PJ
    Palliat Med; 1997 May; 11(3):233-9. PubMed ID: 9205657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the use of a transdermal fentanyl patch in cats.
    Scherk-Nixon M
    J Am Anim Hosp Assoc; 1996; 32(1):19-24. PubMed ID: 8963731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal follow-up of TTS-fentanyl use in patients with cancer-related pain: results of a compassionate-use study with special focus on elderly patients.
    Menten J; Desmedt M; Lossignol D; Mullie A
    Curr Med Res Opin; 2002; 18(8):488-98. PubMed ID: 12564660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal fentanyl: new preparation. An alternative to morphine.
    Prescrire Int; 1998 Oct; 7(37):137-40. PubMed ID: 10915416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor pain. Fentanyl TTS: a transdermal system for tumor pain therapy].
    Dtsch Med Wochenschr; 1995 Oct; 120(41 Suppl):1-4. PubMed ID: 9022357
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug utilization review on a tertiary palliative care unit.
    Llanes LR; Fassbender K; Baracos VE; Watanabe S
    J Pain Symptom Manage; 2006 May; 31(5):457-64. PubMed ID: 16716876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of fentanyl in cancer-related pain.
    Prommer E
    J Palliat Med; 2009 Oct; 12(10):947-54. PubMed ID: 19807240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Economic evaluation of the fentanyl transdermal system.
    Dukes EM; Dhanda R
    J Pain Symptom Manage; 2001 Jul; 22(1):538-40; author reply 541-3. PubMed ID: 11523516
    [No Abstract]   [Full Text] [Related]  

  • 20. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.